Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report.
J Immunother Cancer
; 11(2)2023 02.
Article
in En
| MEDLINE
| ID: mdl-36750254
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immune Checkpoint Inhibitors
/
Melanoma
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: